Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Price Performance

RVP stock opened at $0.72 on Tuesday. The firm has a market cap of $21.56 million, a P/E ratio of -2.77 and a beta of 2.08. The firm’s fifty day moving average is $1.00 and its 200 day moving average is $1.07. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. Retractable Technologies has a 52 week low of $0.71 and a 52 week high of $1.34.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The business had revenue of $6.03 million during the quarter.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.